Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Pasternack

Showing results (271-280 of 285) with videos related to

Pageof 29
Sort By:
Clinica Chimica Acta; International Journal of Clinical Chemistry|August 8, 1997
Fast 5-hour determination of angiotensin-converting enzyme genotypes from blood by SDS-PAGE using PhastSystemX H Huang, T Koivula, E Ilveskoski, et al.
Metabolism: Clinical and Experimental|October 22, 1998
Angiotensin-converting enzyme gene polymorphism is associated with coronary heart disease in non-insulin-dependent diabetic patients evaluated for 9 yearsX H Huang, V Rantalaiho, O Wirta, et al.
Nephron|September 8, 1998
Angiotensin-converting enzyme insertion/deletion polymorphism and diabetic albuminuria in patients with NIDDM followed Up for 9 yearsX H Huang, V Rantalaiho, O Wirta, et al.
Kidney International|September 30, 2000
Renal function and blood pressure five years after puumala virus-induced nephropathyS Mäkelä, I Ala-Houhala, J Mustonen, et al.
Atherosclerosis|June 28, 2001
Remnant-like lipoprotein particle cholesterol concentration and progression of coronary and vein-graft atherosclerosis in response to gemfibrozil treatmentF Karpe, M R Taskinen, M S Nieminen, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 28, 2001
Polymorphism of the cytokine genes in hospitalized patients with Puumala hantavirus infectionS Mäkelä, M Hurme, I Ala-Houhala, et al.
Controlled Clinical Trials|February 1, 1997
A study to determine the response of coronary atherosclerosis to raising low high density lipoprotein cholesterol with a fibric-acid derivative in men after coronary bypass surgery. The rationale, design, and baseline characteristics of the LOCAT Study. Lopid Coronary Angiography TrialM Syvänne, M R Taskinen, Nieminen, et al.
Circulation|October 23, 1997
Prevention of the angiographic progression of coronary and vein-graft atherosclerosis by gemfibrozil after coronary bypass surgery in men with low levels of HDL cholesterol. Lopid Coronary Angiography Trial (LOCAT) Study GroupM H Frick, M Syvänne, M S Nieminen, et al.
Atherosclerosis|August 12, 1998
The 5A/6A polymorphism in the promoter of the stromelysin-1 (MMP-3) gene predicts progression of angiographically determined coronary artery disease in men in the LOCAT gemfibrozil study. Lopid Coronary Angiography TrialS E Humphries, L A Luong, P J Talmud, et al.
Free Radical Research|October 28, 1998
The level of autoantibodies against oxidized LDL is not associated with the presence of coronary heart disease or diabetic kidney disease in patients with non-insulin-dependent diabetes mellitusJ S Leinonen, V Rantalaiho, P Laippala, et al.
Pageof 29

Showing results (271-280 of 285) with videos related to

Sort By:
Pageof 29
Clinica Chimica Acta; International Journal of Clinical Chemistry|August 8, 1997
Fast 5-hour determination of angiotensin-converting enzyme genotypes from blood by SDS-PAGE using PhastSystemX H Huang, T Koivula, E Ilveskoski, et al.
Metabolism: Clinical and Experimental|October 22, 1998
Angiotensin-converting enzyme gene polymorphism is associated with coronary heart disease in non-insulin-dependent diabetic patients evaluated for 9 yearsX H Huang, V Rantalaiho, O Wirta, et al.
Nephron|September 8, 1998
Angiotensin-converting enzyme insertion/deletion polymorphism and diabetic albuminuria in patients with NIDDM followed Up for 9 yearsX H Huang, V Rantalaiho, O Wirta, et al.
Kidney International|September 30, 2000
Renal function and blood pressure five years after puumala virus-induced nephropathyS Mäkelä, I Ala-Houhala, J Mustonen, et al.
Atherosclerosis|June 28, 2001
Remnant-like lipoprotein particle cholesterol concentration and progression of coronary and vein-graft atherosclerosis in response to gemfibrozil treatmentF Karpe, M R Taskinen, M S Nieminen, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 28, 2001
Polymorphism of the cytokine genes in hospitalized patients with Puumala hantavirus infectionS Mäkelä, M Hurme, I Ala-Houhala, et al.
Controlled Clinical Trials|February 1, 1997
A study to determine the response of coronary atherosclerosis to raising low high density lipoprotein cholesterol with a fibric-acid derivative in men after coronary bypass surgery. The rationale, design, and baseline characteristics of the LOCAT Study. Lopid Coronary Angiography TrialM Syvänne, M R Taskinen, Nieminen, et al.
Circulation|October 23, 1997
Prevention of the angiographic progression of coronary and vein-graft atherosclerosis by gemfibrozil after coronary bypass surgery in men with low levels of HDL cholesterol. Lopid Coronary Angiography Trial (LOCAT) Study GroupM H Frick, M Syvänne, M S Nieminen, et al.
Atherosclerosis|August 12, 1998
The 5A/6A polymorphism in the promoter of the stromelysin-1 (MMP-3) gene predicts progression of angiographically determined coronary artery disease in men in the LOCAT gemfibrozil study. Lopid Coronary Angiography TrialS E Humphries, L A Luong, P J Talmud, et al.
Free Radical Research|October 28, 1998
The level of autoantibodies against oxidized LDL is not associated with the presence of coronary heart disease or diabetic kidney disease in patients with non-insulin-dependent diabetes mellitusJ S Leinonen, V Rantalaiho, P Laippala, et al.
Pageof 29